IP Library Granted Patent US 6,891,070
Granted Patent B2
US 6,891,070 · App. 10/474,717 · Granted May 10, 2005

Method for the preparation of 2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]ethoxy}ethanol and its isomers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,891,070
App. No.
10/474,717
Granted
May 10, 2005
Kind
B2
Abstract

A new method for the preparation of a selective estrogen receptor modulator and its isomers. Also disclosed is the preparation of new intermediates and their use in the preparation of the selective estrogen receptor modulator.

Claims (18)

1. Method for the preparation of the compound (I), which is therapeutically useful as a selective estrogen receptor modulator,

wherein

a) a compound of formula (II)

R—O—CH 2 CH 2 —O—CH 2 CH 2 —R′  (II)

where R is a protecting group and R′ is halogen, —OSO 2 CH 3 or tosylate, is reacted with 4-hydroxybenzophenone to give a compound of formula (III),

b) the compound (III) is reacted with cinnamaldehyde and LiAlH 4 in a suitable solvent to give a compound of formula (IV)

c) the compound (IV) is reacted with thionyl chloride in a suitable solvent to give a compound of formula (V)

and

d) the protecting group R is removed from the compound (V) to give the compound of formula (I).

2. The method of claim 1 , wherein the protecting group R is allyl, benzyl or substituted benzyl.

3. The method of claim 1 , wherein the reaction in step a) is carried out as a phase-transfer catalysis, and the solvent in step b) is tetrahydrofuran and the solvent in step c) is toluene.

4. The method of claim 1 , wherein the removal of the protecting group in step d) is carried out i) by hydrogenation with metal catalyst in appropriate solvent or ii) by selective cleavage of a nonaromatic ether with Zn/Acyl chloride.

5. A compound of formula (IV)

wherein R is a protecting group.

6. A compound of formula (V)

wherein R is allyl, benzyl or substituted benzyl.

7. The compound of (V) claim 6 , wherein R is benzyl.

8. The method of claim 1 , wherein R′ is Cl.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2014
From: QUATRX PHARMACEUTICALS COMPANY; HORMOS MEDICAL LTD.
To: FORENDO PHARMA LTD.
Reel/Frame 033795/0443 →
CHANGE OF NAME Recorded Mar 12, 2013
From: HORMOS MEDICAL CORPORATION
To: HORMOS MEDICAL LTD.
Reel/Frame 029970/0810 →
RELEASE OF SECURITY INTEREST Recorded Mar 11, 2013
From: HERCULES TECHNOLOGY GROWTH CAPITAL INC.
To: QUATRX PHARMACEUTICALS COMPANY
Reel/Frame 029963/0829 →
SECURITY AGREEMENT Recorded Apr 24, 2009
From: QUATRX PHARMACEUTICALS COMPANY
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 022584/0669 →
SEE RECORDING AT REEL 015118 FRAME 0851. (THIS IS A DUPLICATE RECORDING) Recorded Oct 10, 2003
From: KALAPUDAS, ARIA; SODERVALL, MARIA
To: HORMOS MEDICAL CORPORATION
Reel/Frame 015087/0778 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2003
From: KALAPUDAS, ARJA; SODERVALL, MARJA
To: HORMOS MEDICAL CORPORATION
Reel/Frame 015118/0851 →